BACKGROUND: Significant disparities exist in cardiovascular outcomes based on
race/ethnicity and gender. Rates of evidence-based medication use and long-term …

Background: Nonadherence to statins limits the benefits of this common drug class.
Individual studies assessing predictors of nonadherence haue produced inconsistent …

Background Nonadherence to chronic disease medications is important. A growing body of
literature suggests that better delivery of established therapies would save more lives than …

Purpose Lipid-lowering medications are often prescribed to decrease the risk of micro-and
macro-cardiovascular complications related to dyslipidaemia. Despite widespread …

Abstract Purpose of Review Cardiovascular disease (CVD) continues to be the leading
cause of death for men and women in the USA. Statins have contributed significantly to …

Purpose Statins are potent drugs for reducing cholesterol and cardiovascular disease;
however, their effectiveness is significantly compromised by poor adherence. This …

Introduction Previous research has shown that statin adherence for the primary prevention of
CVD is lower compared to secondary prevention populations. Therefore the aim of this …

Background Prior studies suggest that persistence with and adherence to statin therapy is
low. Interventions to improve statin persistence and adherence have been developed over …

Statin therapy plays a central role in decreasing the morbidity and mortality associated with
cardiovascular disease. However, prescribed statins are only effective if they are taken by …

Purpose To assess the factors influencing adherence in long‐term medication use as
exemplified by statins. Methods Data from an in‐depth survey of Australians aged 45 years …